Patent Number: 6,309,632

Title: Methods for treating HIV-infected patients by administering GM-CSF

Abstract: Provided are methods for reducing the HIV viral load in HIV-infected patients by administering human GM-CSF. The GM-CSF is administered in conjunction with at least two nucleoside reverse transcriptase inhibitors.

Inventors: Agosti; Jan M. (Seattle, WA)

Assignee: Immunex Corporation

International Classification: A61K 38/19 (20060101); A61K 045/00 ()

Expiration Date: 10/30/2018